6533b823fe1ef96bd127e2b2

RESEARCH PRODUCT

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update

Mireen Friedrich-rustNora CazzagonLaurent CasteraSalvatore PettaAnnalisa BerzigottiMaja ThieleEmmanuel TsochatzisJérôme Boursier

subject

0301 basic medicinemedicine.medical_specialtyelastographyCirrhosisHepatologydecompensationbusiness.industrycirrhosisNon invasiveMEDLINENASHmedicine.diseaseClinical Practice03 medical and health sciencesLiver disease030104 developmental biology0302 clinical medicinemedicine030211 gastroenterology & hepatologyDecompensationIntensive care medicinebusinessserum markers of fibrosiscirrhosis decompensation elastography NASH serum markers of fibrosis

description

Summary Non-invasive tests are increasingly being used to improve the diagnosis and prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for the evaluation of liver disease severity and prognosis, focusing on the topics for which relevant evidence has been published in the last 5 years.

yearjournalcountryeditionlanguage
2021-09-01
10.1016/j.jhep.2021.05.025http://hdl.handle.net/10447/534136